Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
https://doi.org/10.17650/1818-8346-2024-19-3-149-152
Abstract
Evaluation of bone marrow cytogenetic abnormalities in myelodysplastic syndrome is of great importance for confirming the clonal disease nature, determining the prognosis and choosing treatment tactics. Cytogenetic abnormalities are detected in 40–70 % of patients with myelodysplastic syndrome, and the variety of these abnormalities reflects the disease characteristics.
This article describes the clinical follow-up of a patient with a myelodysplastic neoplasia with blast excess 1 and trisomy of chromosome 14.
About the Authors
M. N. PautovaRussian Federation
Marina N. Pautova
41 Kirochnaya St., Saint Petersburg 191015
L. E. Koloskova
Russian Federation
71A Obukhovskoy Oborony Prospekt, Saint Petersburg 192029
O. I. Filippova
Russian Federation
41 Kirochnaya St., Saint Petersburg 191015
A. V. Koloskov
Russian Federation
41 Kirochnaya St., Saint Petersburg 191015
References
1. Khoury J.D., Solary E., Abla O. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 2022;36(7):1703–19. DOI: 10.1038/s41375-022-01613-1
2. Heim S., Mitelman F. Numerical chromosome aberrations in human neoplasia. Cancer Genet Cytogenet 1986;22(2):99–108. DOI: 10.1016/0165-4608(86)90169-x
3. Boavida M.G., Ambrósio P., Dhermy D. et al. Isochromosome 14q in refractory anemia. Cancer Genet Cytogenet 1997;97(2):155–6. DOI: 10.1016/s0165-4608(96)00334-2
4. Haas O.A., Jäger U., Ambros P., Pabinger I. Trisomy 14 in refractory anemia with excess of blasts in transformation. Cancer Genet Cytogenet 1987;29(2):315–8. DOI: 10.1016/0165-4608(87)90242-1
5. Mancini M., Cedrone M., Nanni M. et al. Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders. Cancer Genet Cytogenet 1993;66(1):39–42. DOI: 10.1016/0165-4608(93)90146-d
6. Mertens F., Johansson B., Heim S. et al. Trisomy 14 in atypical chronic myeloid leukemia. Leukemia 1990;4(2):117–20.
7. Reddy K.S. Trisomy 14 and leukemia. Cancer Genet Cytogenet 1998;106(2):144–51. DOI: 10.1016/s0165-4608(98)00053-3
8. Toze C.L., Barnett M.J., Naiman S.C., Horsman D.E. Trisomy 14 is a non-random karyotypic abnormality associated with myeloid malignancies. Br J Haematol 1997;98(1):177–85. DOI: 10.1046/j.1365-2141.1997.1863003.x
9. Horton Y.M., Johnson P.R. Trisomy 14 in myeloid malignancies: report of two cases and review of the literature. Cancer Genet Cytogenet 2001;124(2):172–4. DOI: 10.1016/s0165-4608(00)00345-9
10. Rojas A., Pineda L., González S. et al. Anomalías cromosómicas en enfermedades hematológicas malignas [Chromosomal abnormalities in malignant hematologic diseases (In Spanish)]. Acta Cient Venez 2000;51(2):109–14.
11. Cui W., Bueso-Ramos C.E., Yin C.C. et al. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression. J Biomed Biotechnol 2010;2010:365318. DOI: 10.1155/2010/365318
12. Liu H.W., Lie K.W., Chan L.C. Isochromosome 14q and leukemia with dysplastic features. Cancer Genet Cytogenet 1992;64(1):97–8. DOI: 10.1016/0165-4608(92)90333-4
13. Henderson A.S., Warburton D., Atwood K.C. Location of ribosomal DNA in the human chromosome complement. Proc Natl Acad Sci USA 1972;69(11):3394–8. DOI: 10.1073/pnas.69.11.3394
14. Rossi G., Pelizzari A.M., Bellotti D. et al. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Leukemia 2000;14(4):636–41. DOI: 10.1038/sj.leu.2401711
15. Pinkerton P.H., London B., Dubé I.D., Senn J.S. Trisomy 14q in myelodysplastic syndromes. Cancer Genet Cytogenet 1990;49(1):113–6. DOI: 10.1016/0165-4608(90)90171-6
Review
For citations:
Pautova M.N., Koloskova L.E., Filippova O.I., Koloskov A.V. Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome. Oncohematology. 2024;19(3):149-152. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-3-149-152